
Palivizumab
CAS No. 188039-54-5
Palivizumab( —— )
Catalog No. M36768 CAS No. 188039-54-5
Palivizumab (MEDI 493) is a humanized RSV-specific monoclonal antibody that selectively inhibits epitopes at the F protein A antigenic site of RSV subtypes A and B for the prevention of respiratory syncytial virus infection (RSV).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 347 | Get Quote |
![]() ![]() |
5MG | 549 | Get Quote |
![]() ![]() |
10MG | 785 | Get Quote |
![]() ![]() |
25MG | 1122 | Get Quote |
![]() ![]() |
50MG | 1518 | Get Quote |
![]() ![]() |
100MG | 2007 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NamePalivizumab
-
NoteResearch use only, not for human use.
-
Brief DescriptionPalivizumab (MEDI 493) is a humanized RSV-specific monoclonal antibody that selectively inhibits epitopes at the F protein A antigenic site of RSV subtypes A and B for the prevention of respiratory syncytial virus infection (RSV).
-
DescriptionPalivizumab (MEDI 493), a humanized respiratory syncytial virus monoclonal antibody, reduces respiratory syncytial virus (RSV) infection.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayJAK/STAT Signaling
-
TargetSTAT
-
RecptorRSV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number188039-54-5
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group. Pediatrics. 1998 Sep;102(3 Pt 1):531-7.?
molnova catalog



related products
-
Galiellalactone
A small molecule, direct STAT3 inhibitor that inhibits the IL-6-induced SEAP expression with IC50 of 200-500 nM.
-
Corosolic acid
Corosolic acid contains anti-angiogenic activity that can suppress FAK signaling induced by angiopoietin-1.
-
SD-1029
SD-1029 (NSC 371488) is a potent inhibitor of Stat3 activation.